Search

Inmode Ltd

Abrir

SetorSaúde

15.36 0.07

Visão Geral

Variação de preço das ações

24h

Atual

Mín

15.14

Máximo

15.53

Indicadores-chave

By Trading Economics

Rendimento

-15M

12M

Vendas

-22M

82M

P/E

Médio do Setor

11.306

60.149

EPS

0.25

Margem de lucro

14.097

Funcionários

660

EBITDA

-17M

15M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+10.68% upside

Dividendos

By Acuity

Próximos Ganhos

5 de ago. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-36M

871M

Abertura anterior

15.29

Fecho anterior

15.36

Sentimento de Notícias

By Acuity

50%

50%

156 / 340 Ranking em Healthcare

Inmode Ltd Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

20 de jul. de 2026, 19:26 UTC

News

InMode Ltd faces scrutiny from Bronstein, Gewirtz & Grossman, LLC, over governance issues, contributing to a decline in its stock price since Friday's close.

Comparação entre Pares

Variação de preço

Inmode Ltd Previsão

Preço-alvo

By TipRanks

10.68% parte superior

Previsão para 12 meses

Média 17 USD  10.68%

Máximo 19 USD

Mínimo 15 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Inmode Ltd - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

5 ratings

1

Comprar

4

Manter

0

Vender

Sentimento

By Acuity

156 / 340 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Inmode Ltd

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.
help-icon Live chat